Clinical Trial Update: A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers [Phase 4]

View source ↗

Summary

Phase 4 study comparing immunogenicity and safety of GlaxoSmithKline's Infanrix Hexa (DTPa-HBV-IPV/Hib) versus MCM Vaccine BV's Vaxelis (DTaP5-HBV-IPV-Hib) in h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria

Drugs mentioned

• Infanrix Hexa (DTPa-HBV-IPV/Hib)
• Vaxelis (DTaP5-HBV-IPV-Hib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria | Phase 4 | Status: COMPLETED | Results posted: 2024-03-27